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The present study set out to investigate whether nitric oxide, a potent vasodilator, is involved in the
regulatory processes in optic nerve head blood ﬂow during an experimental increase in intraocular
pressure (IOP). The study was conducted in a randomized, double-masked, placebo-controlled, three way
cross-over design. 12 healthy subjects were scheduled to receive either L-NMMA (an unspeciﬁc nitric
oxide synthase inhibitor), phenylephrine (an a-adrenoceptor agonist) or placebo on three different study
days. Optic nerve head blood ﬂow was measured using laser Doppler ﬂowmetry and IOP was increased
stepwise with a suction cup. Mean arterial pressure (MAP) and IOP were measured non-invasively and
ocular perfusion pressure (OPP) was calculated as OPP ¼ 2/3 MAP-IOP. Administration of L-NMMA and
phenylephrine signiﬁcantly increased MAP and therefore OPP at rest (p < 0.01). L-NMMA signiﬁcantly
reduced baseline blood ﬂow in the optic nerve head (p < 0.01). Application of the suction cup induced a
signiﬁcant increase in IOP and a decrease in OPP (p < 0.01). During the stepwise increase in IOP, some
autoregulatory potential was observed until OPP decreased approximately 30% below baseline. None of
the administered substances had an effect on this autoregulatory behavior (p ¼ 0.49). The results of the
present study conﬁrm that the human optic nerve head shows some regulatory capacity during a
decrease in OPP. Nitric oxide is involved in the regulation of basal vascular tone in the optic nerve head
but does not seem to be involved in the regulatory mechanisms during an acute increase in IOP in young
healthy subjects.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Glaucoma, one of the leading causes of blindness in the indus-
trialized world, is associated with disturbances in ocular blood ﬂow
autoregulation (Schmidl et al., 2011a). The term blood ﬂow autor-
egulation describes the ability of a vascular bed to keep its bloodhy; ONH, optic nerve head;
head blood ﬂow; NO, nitric
de synthase.
armacology, Medical Univer-
a, Austria. Tel.: þ43 1 40400
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r Ltd. Open access under CC BY-NC-NDﬂow stable, despite variations in perfusion pressure. In healthy
subjects it has been shown that a decrease in ocular perfusion
pressure (OPP) does not lead to a parallel decrease in choroidal and
optic nerve head blood ﬂow (Pillunat et al., 1997; Polska et al., 2007;
Riva et al., 1997a,b; Schmidl et al., 2012; Schmidl et al., 2011b;
Simader et al., 2009; Weigert et al., 2005). This is explained by
the presence of a regulatory capacity of the vascular beds, meaning
that blood ﬂow does not decrease despite a decline in OPP (Schmidl
et al., 2011a). However, when OPP decreases below the regulatory
range, blood ﬂow starts to decrease linearly. Evidence for this
behavior comes from human studies as mentioned above, but has
also been observed in rabbits, monkeys, cats and rats (Geijer and
Bill, 1979; Kiel and Shepherd, 1992; Kiel and van Heuven, 1995;
Piper et al., 2013; Riva et al., 1996; Schmidl et al., 2011a; Zhi et al.,
2012).
In patients with glaucoma, reduced OPP has been identiﬁed
as a risk factor for the onset and progression of the disease license.
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angle glaucoma the OPP decrease is caused either by increased
intraocular pressure (IOP) or systemic arterial hypotension, the
latter causes low OPP in normal tension glaucoma (De Moraes
et al., 2012; Grover and Budenz, 2011; Okumura et al., 2012;
Topouzis et al., 2013). Further, short-term ﬂuctuations in OPP
have been found to be a risk factor for the disease (Mroczkowska
et al., 2013; Quaranta et al., 2013; Sung et al., 2009).
These results in combination with ﬁndings that ocular blood
ﬂow is often reduced in patients with glaucoma support the
concept of impaired blood ﬂow autoregulation in glaucoma
(Fuchsjager-Mayrl et al., 2004; Hafez et al., 2003; Yanagi et al.,
2011). Indeed, blood ﬂow autoregulation has been found to be
abnormal in patients with glaucoma (Cherecheanu et al., 2013; Feke
and Pasquale, 2008; Kochkorov et al., 2010; Portmann et al., 2011;
Schmidl et al., 2011a). Especially, optic nerve head blood ﬂow
(ONHBF) seems to be important, since the optic nerve head (ONH)
is most likely the location of the primary insult in glaucomatous
optic neuropathy (GON) (Malik et al., 2012; Venkataraman et al.,
2010).
The Nitric Oxide/Endothelin system has been proposed as a
possible target to improve blood ﬂow regulation in glaucoma,
because it is an important regulator of vascular endothelial tone in
the ocular circulation (Haeﬂiger et al., 2001). For the choroid it has
been shown that both substances are involved in blood ﬂow
regulation during an experimental increase in OPP in healthy
subjects (Fuchsjager-Mayrl et al., 2003; Luksch et al., 2003). In the
ONH, administration of a nitric oxide synthase (NOS) inhibitor
reduced baseline ONHBF, but did not alter the autoregulatory
behavior during isometric exercise (Schmidl et al., 2013). In
contrast, blockade of the EndothelinA receptor had no effect on
baseline ONHBF but signiﬁcantly altered the response of ONHBF to
isometric exercise (Boltz et al., 2013). In the present study, we set
out to investigate whether NOS inhibition has an effect on ONHBF
blood ﬂow regulation during an experimental increase in IOP in
healthy subjects. This was done in an effort to gain more insight in
the process underlying ONHBF regulation during a decrease in OPP.
2. Material and methods
2.1. Subjects
The present study was performed in adherence to the Declara-
tion of Helsinki and the Good Clinical Practice (GCP) guidelines of
the European Union. The study protocol was approved by the Ethics
Committee of the Medical University of Vienna. After written
informed consent was obtained, 12 healthy female and male sub-
jects completed the present study (age: 25.7  3.6 years,
mean SD). The sample size calculationwas based on unpublished
results from previous measurements of ONHBF during an increase
in IOP in our laboratory. A repeated measures ANOVA model was
underlying this sample size calculation. These data were used for
the sample size calculation selecting an a-error of 0.05 and a power
of 0.80 and aiming to measure a difference between treatment
arms of 10%. Changes in ONHBF below 10% were assumed to be
irrelevant.
During the four weeks before the ﬁrst study day, a screening
examination was performed which included recording of medical
history and a physical examination, 12-lead electrocardiogram, and
assessment of laboratory values (hemoglobin, hematocrit, RBC,
MCH, WBC, platelet count, aPTT, thrombin time, sodium, potas-
sium, creatinine, GPT (ALAT), g-GT, total bilirubin, total protein,
Hepatitis B, C and HIV-Serology and urine analysis). In addition, a
full ophthalmologic examination was performed. If any clinically
relevant abnormality was found as part of the screeningexamination the subject was not included. In addition, only sub-
jects with ametropia of less than 1 diopter and no evidence of eye
disease were recruited to participate in the trial. In the three weeks
before the ﬁrst study day and during the course of the study no
intake of concomitant medication was allowed, except oral con-
traceptives. During the week after completion of the study, a follow
up safety investigation similar to the pretreatment examination
was performed.
2.2. Drugs and drug administration
NG-monomethyl-L-arginine (L-NMMA, Bachem Distribution
Services GmbH, Weil am Rhein, Germany): A bolus of 6 mg/kg over
5 min followed by a continuous infusion of 60 mg/kg/min over
15 min (Schmidl et al., 2013) was applied.
Phenylephrine (Neosynephrine, Winthrop Breon Laboratories
New York, NY, USA): 1 mg/kg/min was administered over an infu-
sion period of 20 min. Since administration of L-NMMA leads to a
slight increase in systemic blood pressure at rest (Campbell et al.,
2011; Haynes et al., 1993; Mayer et al., 1999), phenylephrine was
used as control so that subjects would start at similar OPPs.
Phenylephrine has no effect on ocular hemodynamics and in the
administered dose has similar effects on systemic blood pressure
(Luksch et al., 2003; Schmetterer et al., 1996; Simader et al., 2009).
Physiological saline solution was used as placebo.
A bolus over 5 min followed by a continuous infusion over
15 min of phenylephrine or placebo were prepared and infused
subsequently to allow for double-masked conditions.
2.3. Methods
2.3.1. Noninvasive measurement of systemic hemodynamics and
OPP
An automated oscillometric device was used for measurement
of systolic, diastolic and mean arterial pressure (SBP, DBP, MAP) on
the upper arm. Pulse rate (PR) was automatically recorded from a
ﬁnger pulse-oxymetric device (HP-CMS patient monitor, Hewlett
Packard, Palo Alto, CA, USA). Ocular perfusion pressure (OPP) was
estimated 2/3 MAP e IOP (Robinson et al., 1986).
2.3.2. Laser Doppler ﬂowmetry (LDF)
Measurement of ONH blood ﬂow was performed using a laser
Doppler ﬂowmeter with fundus view (Riva et al., 2010, 1992). With
this device the vascularized tissue is illuminated by coherent laser
light. Scattering on moving red blood cells (RBCs) leads to a fre-
quency shift in the scattered light. In contrast static components in
tissue do not change light frequency, but lead to randomization of
light directions impinging on RBCs. This light diffusing in vascu-
larized tissue leads to a broadening of the spectrum of scattered
light, from which mean RBC velocity (vel), the blood volume (vol),
and blood ﬂow (ﬂow) can be calculated in relative units. In the
present study laser Doppler ﬂowmetry was performed at the
inferior temporal neuroretinal rim to assess ONH blood ﬂow.
2.3.3. Intraocular pressure
A slit-lamp mounted Goldmann applanation tonometer was
used to measure IOP. Before each measurement, one drop of 0.4%
benoxinate hydrochloride combinedwith 0.25% sodium ﬂuorescein
was used to achieve local anesthesia of the cornea.
2.3.4. Suction cup method
To increase IOP, the episcleral suction-cup technique ﬁrst
described by Ulrich and co-workers was used (Ulrich and Ulrich,
1985). The eye was topically anesthetized and a rigid standard-
ized 11-mm diameter plastic suction cup was placed on the
Table 1
Baseline data on each study day.
Placebo day Phenylephrine
day
L-NMMA
day
Systolic Blood Pressure (mmHg) 116.4  12.1 113.5  7.5 109.8  9.6
Diastolic Blood Pressure (mmHg) 60.3  7.6 58.6  7.6 59.4  6.7
Mean Arterial Pressure (mmHg) 80.4  7.2 77.7  7.4 77.8  6.9
Heart Rate (bpm1) 68.6  11.2 73.4  9.8 74.6  10.7
Intraocular Pressure (mmHg) 13.6  2.0 13.7  2.0 13.3  2.1
Ocular Perfusion Pressure
(mmHg)
40.0  5.5 38.1  4.9 38.6  4.8
Optic Nerve Head Blood
Flow (a.u.)
21.6  5.3 21.5  4.6 23.2  3.8
Mean  SD; n ¼ 12.
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limbus. Through plastic tubing, the suction cupwas connected to an
automatic suction pump, which was used to stepwise increase the
vacuum from 25 mmHg to 125 mmHg resulting in an IOP increase.
2.4. Study design
The study was performed in a randomized, double-masked,
placebo-controlled, three-way cross over design. Subjects were
assigned to receive intravenous infusions of L-NMMA, phenyleph-
rine or physiologic saline solution on three different study days. A
minimumwashout-period between the study days of four days was
scheduled for each subject.
The time schedule (Fig. 1) was based on a design used in a study
conducted previously in our laboratory (Simader et al., 2009).
Subjects had to abstain from alcohol and stimulating beverages
containing xanthine derivatives 12 h before each study day. On the
trial days subjects arrived after a light meal and sleep for 7e8 h and
a resting period of at least 20 min was scheduled to obtain stable
hemodynamic conditions. Afterward, measurements of ocular and
systemic hemodynamics were performed. ONHBF was measured
continuously for two minutes at baseline. Thereafter IOP was
increased stepwise by applying the suction cup at levels of 25, 50,
75, 100 and 125 mmHg for one minute each. ONHBF was measured
continuously and systemic hemodynamics were assessed every
minute. Since IOP measurement by applanation tonometry simul-
taneously with ONHBF measurements is impossible, a second
period of suctionwas scheduled 30min later to obtain IOP values at
each level of suction. After another resting period of at least 30 min
drug administration was started. During the last 5 min of drug
administration a ﬁnal period of IOP elevation was scheduled and
ONHBF was measured continuously.
2.5. Data analysis
The polynomial correction approach was applied to correct for
unstable reference signals (direct current, DC, Gugleta et al., 2002).
Brieﬂy, the parameter “yield” was calculated as DC/gain. A regres-
sion model applying a third-order polynomial equation was used
on the logarithmic values of yield and the respective LDF parame-
ters to calculate the corrected LDF data.
A repeated measures ANOVA model was used to detect differ-
ences between the treatments. Post hoc analyses were done using
planned comparisons. For this purpose the time effect was used to
characterize the effect of IOP increase on the outcome parameters.
A p-value < 0.05 was considered the level of signiﬁcance.Fig. 1. Illustration of the time schedule (ONHBF-optic nerve heaIn addition, data were expressed as %change in OPP and ﬂow
values over baseline to show pressureeﬂow relationships. OPP
values were sorted according to descending values and grouped
into 6 categories. As such 12 values were classiﬁed in each of the
groups. A statistically signiﬁcant deviation from baseline ﬂow was
deﬁned when the 95% conﬁdence interval did not overlap with the
baseline value any more. Statistical analysis was carried out using
CSS Statistica for Windows (Statsoft Inc., Version 6.0, Tulsa,
Oklahoma).3. Results
Fourteen volunteers were initially included, of which twelve
subjects aged between 20 and 32 years ﬁnished the study according
to the protocol. Two subjects dropped out of the study because they
did not tolerate the application of the suction cup. Except localized
mild conjunctival hyperemia, no adverse event was observed after
suction cup application. No signiﬁcant differences were found be-
tween the baseline values on the 3 study days (Table 1).
The application of the suction cup at different suction levels
caused a highly signiﬁcant increase in IOP, which was similar on all
three study days during the pre-treatment period (p < 0.01 versus
baseline). The IOP reached maximum values between
40.3 2.3 mmHg and 41.3 2.2 mmHg on the three study days. No
effect of suction on MAP or HR was observed (Figs. 2 and 3). Hence,
OPP signiﬁcantly decreased during application of the suction cup
(p < 0.01 versus baseline, Fig. 4). This effect was comparable on all
study days (p ¼ 0.64). A signiﬁcant decrease in ONHBF accompa-
nied this decrease in OPP during the pre-treatment periods
(maximal reduction between 45.3  3.0% and 46.3  3.0%,
p < 0.01 versus baseline, Fig. 5).d blood ﬂow, BP-blood pressure, IOP-intraocular pressure).
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Fig. 4. Relative change in ocular perfusion pressure (OPP) during application of the
suction cup. The ﬁrst period was done without drug administration, the second period
during infusion of L-NMMA (circles), phenylephrine (PE, triangles) or placebo
(squares). Data are presented as mean  SD (n ¼ 12). * signiﬁcant changes vs. baseline.
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istration of L-NMMA and phenylephrine induced a signiﬁcant in-
crease in MAP (Fig. 2, p < 0.01 versus baseline), but there was no
signiﬁcant difference in the systemic hypertensive response be-
tween the two agents (p ¼ 0.94). IOP was comparable with all
administered drugs before application of the suction cup. Hence,
OPP increased after administration of L-NMMA and phenylephrine,
but not after infusion of placebo (p < 0.01). Heart rate decreased
signiﬁcantly after administration of L-NMMA and phenylephrine,
which was again signiﬁcant versus placebo (p < 0.01, Fig. 3). Pla-
cebo and phenylephrine did not alter ONHBF at baseline. Admin-
istration of L-NMMA, however, induced a signiﬁcant decrease in45
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Fig. 3. The effect of the study drugs on heart rate. The ﬁrst period was done without
drug administration, the second period during infusion of L-NMMA (circles), phenyl-
ephrine (PE, triangles) or placebo (squares). Data are presented as the mean  SD
(n ¼ 12). * signiﬁcant changes vs. baseline, # signiﬁcant effects of PE and L-NMMA on
baseline parameters vs. placebo.ONHBF before application of the suction cup (p < 0.01 versus pla-
cebo). During the artiﬁcial increase in IOP, no difference in the
response of OPP between the three administered drugs was
observed (p ¼ 0.24, Fig. 4). Similar changes in ONHBF were
measured during infusion of placebo (52.0  9.3% at maximum),
L-NMMA (47.4  11.2% at maximum), and phenylephrine
(42.1  8.7% at maximum) when OPP was decreased (p ¼ 0.49,
Fig. 5).
When grouping the data according to descending OPP values to
determine the pressureeﬂow relationship no difference between
the three administered drugs was found (Fig. 6). Pressure-ﬂow-50
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4. Discussion
The data obtained in the present study conﬁrm previous ﬁnd-
ings that the ONH shows some autoregulatory potential during an
experimental increase in IOP (Riva et al., 1997a; Schmidl et al.,
2012). ONHBF did not decrease signiﬁcantly until OPP values
30% below baseline were reached. This is in concordance with a
study previously performed in our laboratory, where ONHBF left
the autoregulatory range when OPP decreased 29% below base-
line (Schmidl et al., 2012).
The ANOVA model revealed no signiﬁcant difference between
the three administered agents, indicating that NO is not involved in
ONHBF autoregulation during an experimental increase in IOP.
While we found no evidence that NO is involved in ONHBF autor-
egulation during an experimental decrease in OPP, animal studies
found that NO plays a role in ONHBF autoregulation during a
decrease in OPP. In a rabbit study conducted by Okuno et al. (2002),
IOP was increased and held constant at 50 mmHg for 60 min. In-
hibition of NOS signiﬁcantly altered the autoregulatory response in
ONH blood ﬂow as assessed with the hydrogen clearance technique
and prolonged the visual evoked potential implicit times (Okuno
et al., 2002). In another study, a rapid increase of IOP from
20 mmHg to either 40 mmHg or 50 mmHg induced no signiﬁcant
changes in ONHBF in rabbits (Takayama et al., 2003) indicating for
efﬁcient autoregulation. When IOP was, however, increased to
60 mmHg, a signiﬁcant decrease in ONHBF was seen, which lasted
for the whole 60 min of IOP increase (Takayama et al., 2003). In-
hibition of NO-synthase had little effect on ONH blood ﬂow during
the increase in IOP. These animal experiments are, however, not
directly comparable to the data of the present study. In our ex-
periments, we only reached IOP levels of approximately 40 mmHg
at the highest level of suction for 1 min and much shorter period of
IOP elevation were used. In addition, when IOP is elevated for a
longer period of time, the resulting hypoxia caused by the reduc-
tion in blood ﬂow could lead to the initiation of metabolic mech-
anisms releasing NO (Pournaras et al., 2008). In the retina of cats,
hypoxia induced a signiﬁcant vasodilatation of retinal vessels and a
signiﬁcant increase in retinal blood ﬂow, which was diminishedwhen a NOS inhibitor was administered intravitreously (Nagaoka
et al., 2002). Whether NO-synthase inhibition would affect ONH
blood ﬂow regulation during a longer period of IOP elevation can
obviously not be investigated in humans.
When looking at the present data, it also has to be considered
that the superﬁcial layers of the ONH are supplied by the central
retinal artery while the deeper pre-laminar regions obtain its blood
from the posterior ciliary arteries deriving (Caprioli and Coleman,
2010; Ciofﬁ et al., 2003; Schmidl et al., 2013). A limitation of LDF
as applied in the present study is that it mainly measures blood
ﬂow in the superﬁcial layers of the ONH (Petrig et al., 1999) and it
could therefore be speculated that a similar response in retinal
blood ﬂow to inhibition of NOS during a decrease in OPP should be
observed. Indeed, during a decrease in OPP in experimental ani-
mals, administration of an unspeciﬁc NOS inhibitor did not alter the
autoregulatory response of retinal blood ﬂow (Hardy et al., 1996;
Harino et al., 1999), as observed in our study focusing on the ONH.
The data obtained in our study indicate that NO is involved in
basal ONHBF regulation, because administration of L-NMMA
caused a signiﬁcant decrease of blood ﬂow before application of the
suction cup. This is in concordance with previous ﬁndings, where
NOS inhibition caused a signiﬁcant decrease in ONHBF in healthy
subjects as well as in experimental animals (Luksch et al., 2000;
Mayama et al., 2012; Polak et al., 2007; Schmidl et al., 2013;
Sugiyama et al., 2000; Takayama et al., 2003). Three different NOS
have been identiﬁed, namely endothelial NOS (eNOS), neural
(nNOS) and inducible (iNOS). NO stimulates guanylyl cyclase, which
then leads to the synthesis of cyclic guanosine monophosphate. In
response, a calcium efﬂux out of the cell is induced, leading to
relaxation of the smooth muscle cell (Schmetterer and Polak, 2001;
Schmidl et al., 2011a). L-NMMA is a non-speciﬁc inhibitor of NO
synthase and as such all constitutive forms of NO synthase can be
blocked by its administration. It can, however, be excluded that
iNOS blockade was observed in the present study since iNOS is only
released under pathological conditions after several hours
(Salvemini et al., 2013). Involvement of nNOS is possible, but does
not seem to be expressed in the superﬁcial layer of the ONH, in
which the blood ﬂow measurements were performed (Schmidl
et al., 2013; Shareef et al., 1999). Therefore, the observed reduc-
tion in basal ONHBF after administration of L-NMMA seems to be
primarily caused by inhibition of eNOS (Schmidl et al., 2013).
A number of limitations need to be considered for the present
study. As mentioned above, with LDF the superﬁcial layers of the
ONH are primarily measured (Petrig et al., 1999). The vascular
supply of the ONH is, however, complex (Mackenzie and Ciofﬁ,
2008) and the deeper vascular layers may well react differently.
In previous papers we have discussed this limitation in more detail
(Petrig et al., 1999; Schmidl et al., 2013, 2012). In addition, some
concerns have been raised dealing with the speciﬁcity of L-NMMA
as an inhibitor of NO synthase (Iadecola et al., 1994; Peterson et al.,
1992). We have, however, previously shown that the ocular he-
modynamic effects of L-NMMA can be reversed by high-dose L-
arginine (Schmetterer et al., 1997). The present study was carried
out in young healthy subjects and only addressed short term
changes in OPP. Patients with open angle glaucoma, however, are
usually older and the disease develops over a longer period of time
with IOP values usually below the highest observed values in our
trial. Obviously, studies using prolonged experimental IOP increase
in healthy subjects are ethically not justiﬁed. As such the hemo-
dynamic consequences of long-term IOP elevation are not well
described. It has, however, been well established that low OPP is a
risk factor for the onset and progression of primary open angle
glaucoma (Cherecheanu et al., 2013; Leske, 2009; Schmidl et al.,
2011a). In addition, the correlation between ONHBF and OPP has
been found to be more linear in patients with untreated glaucoma
D. Schmidl et al. / Experimental Eye Research 116 (2013) 247e253252compared to healthy controls, indicating disturbed blood ﬂow
autoregulation (Fuchsjager-Mayrl et al., 2004). Since the NO system
seems to be altered in patients with glaucoma, it is possible it
contributes to ONH ischemia and abnormal autoregulation
(Cherecheanu et al., 2013; Polak et al., 2007; Schmidl et al., 2011a)
although further studies on this topic are required.
5. Conclusion
In conclusion, our results conﬁrm previous ﬁndings that ONHBF
is to some degree autoregulated in response to an experimental
increase in IOP. NO does not seem to be involved in ONH blood ﬂow
autoregulation during an experimental decrease in OPP. Our data,
however, conﬁrm several reports in the literature that NO is an
important regulator of basal vascular tone in the ONH.
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